[go: up one dir, main page]

NO983540L - Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering - Google Patents

Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering

Info

Publication number
NO983540L
NO983540L NO983540A NO983540A NO983540L NO 983540 L NO983540 L NO 983540L NO 983540 A NO983540 A NO 983540A NO 983540 A NO983540 A NO 983540A NO 983540 L NO983540 L NO 983540L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations containing
stabilized against
against racemization
cilansetron
Prior art date
Application number
NO983540A
Other languages
English (en)
Other versions
NO323229B1 (no
NO983540D0 (no
Inventor
Ingo Bonnacker
Hartmut Koehn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO983540D0 publication Critical patent/NO983540D0/no
Publication of NO983540L publication Critical patent/NO983540L/no
Publication of NO323229B1 publication Critical patent/NO323229B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19983540A 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater NO323229B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01
DE19813661A DE19813661A1 (de) 1997-08-01 1998-03-27 Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron

Publications (3)

Publication Number Publication Date
NO983540D0 NO983540D0 (no) 1998-07-31
NO983540L true NO983540L (no) 1999-02-02
NO323229B1 NO323229B1 (no) 2007-02-05

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983540A NO323229B1 (no) 1997-08-01 1998-07-31 Flytende eller faste farmasoytiske preparater inneholdende cilansetron stabilisert mot racemisering, anvendelse av sure tilsetningsstoffer til stabiliseringen og fremgangsmate for fremstilling av slike faste preparater

Country Status (28)

Country Link
US (1) US5977127A (no)
EP (1) EP0895782B1 (no)
JP (1) JP4324260B2 (no)
KR (1) KR100515201B1 (no)
CN (1) CN1117565C (no)
AR (1) AR010178A1 (no)
AT (1) ATE283706T1 (no)
AU (1) AU743043B2 (no)
BR (1) BR9803730A (no)
CA (1) CA2244389C (no)
CZ (1) CZ295072B6 (no)
DE (2) DE19813661A1 (no)
DK (1) DK0895782T3 (no)
DZ (1) DZ2560A1 (no)
ES (1) ES2234051T3 (no)
HU (1) HUP9801712A3 (no)
ID (1) ID20685A (no)
IL (1) IL125403A (no)
NO (1) NO323229B1 (no)
NZ (1) NZ331083A (no)
PL (1) PL191767B1 (no)
PT (1) PT895782E (no)
RU (1) RU2199318C2 (no)
SK (1) SK284916B6 (no)
TR (1) TR199801432A3 (no)
TW (1) TW509570B (no)
UA (1) UA62924C2 (no)
ZA (1) ZA986715B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
CN100350911C (zh) * 2001-03-26 2007-11-28 诺瓦提斯公司 含有水溶性差的活性成分、表面活性剂和水溶性聚合物的药物组合物
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
AU2004204827B2 (en) * 2003-01-13 2006-06-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
CN100353946C (zh) * 2003-01-13 2007-12-12 戴诺吉药品有限公司 治疗功能性肠病的方法
WO2004089288A2 (en) * 2003-04-04 2004-10-21 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
CN102186474A (zh) * 2008-08-14 2011-09-14 杏林制药株式会社 稳定的医药组合物
WO2021100728A1 (ja) 2019-11-20 2021-05-27 塩野義製薬株式会社 6,7-不飽和-7-カルバモイルモルヒナン誘導体含有固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
PL191767B1 (pl) 2006-06-30
CZ295072B6 (cs) 2005-05-18
IL125403A0 (en) 1999-03-12
CA2244389C (en) 2008-01-15
CA2244389A1 (en) 1999-02-01
US5977127A (en) 1999-11-02
IL125403A (en) 2001-11-25
ZA986715B (en) 1999-02-04
NZ331083A (en) 2000-01-28
CN1117565C (zh) 2003-08-13
ATE283706T1 (de) 2004-12-15
AU743043B2 (en) 2002-01-17
EP0895782A3 (de) 2001-01-31
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15
AU7863098A (en) 1999-02-11
EP0895782B1 (de) 2004-12-01
DE19813661A1 (de) 1999-02-04
KR100515201B1 (ko) 2005-12-09
RU2199318C2 (ru) 2003-02-27
ES2234051T3 (es) 2005-06-16
TR199801432A2 (xx) 1999-02-22
BR9803730A (pt) 2000-03-28
DE59812317D1 (de) 2005-01-05
HU9801712D0 (en) 1998-09-28
SK100998A3 (en) 1999-02-11
TW509570B (en) 2002-11-11
JP4324260B2 (ja) 2009-09-02
HK1017611A1 (en) 1999-11-26
TR199801432A3 (tr) 1999-02-22
PL327786A1 (en) 1999-02-15
HUP9801712A3 (en) 2001-08-28
JPH1192369A (ja) 1999-04-06
NO323229B1 (no) 2007-02-05
EP0895782A2 (de) 1999-02-10
CZ236798A3 (cs) 1999-02-17
NO983540D0 (no) 1998-07-31
DZ2560A1 (fr) 2003-02-15
CN1207292A (zh) 1999-02-10
SK284916B6 (sk) 2006-02-02
PT895782E (pt) 2005-02-28
ID20685A (id) 1999-02-18
HUP9801712A2 (hu) 1999-04-28
DK0895782T3 (da) 2005-01-03
AR010178A1 (es) 2000-05-17

Similar Documents

Publication Publication Date Title
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
NO974618D0 (no) Farmasöytiske preparater for intranasal administrasjon
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
IS5058A (is) Samverkandi súlfónýlþvagefnis-glitasónsblöndur við sykursýki
DK0998272T3 (da) Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
NO983540L (no) Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering
NO974934L (no) 10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
DE69926012D1 (de) Arzneizubereitungen
FI955968L (fi) Annostelija kiinteitä lääkeaineita varten
EE9800275A (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
DE69811367D1 (de) Cis-substituierte fluoromethylpyrrolidin-derivate
NO995653D0 (no) Cis-substituerte aminocykloalkyl-pyrrolidin-derivater
NO20003141D0 (no) Farmasøytiske blandinger
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
DE69906934D1 (de) Arzneizubereitungen
FI931918A7 (fi) Transportanordning foer en balk som skall foerflyttas i laengsriktningen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees